Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Kaleido Biosciences closes $101mm Series C round

Executive Summary

Kaleido Biosciences (optimizing the human microbiome to treat disease) raised $101mm through its Series C round. Founding investor Flagship Pioneering participated, along with a subsidiary of the Abu Dhabi Investment Authority, Fidelity Management & Research, Invus, and Rock Springs Capital.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies